SCH-1473759 hydrochloride is a multi-targeted aurora kinase inhibitor with potential antitumor activity; it inhibits proliferation of various human tumor cell lines derived from breast, ovarian, prostate, lung, colon, brain, gastric, renal, skin, and leukemia tissues; it demonstrates dose- and schedule-dependent antitumor efficacy in human tumor xenograft models; its antitumor activity is enhanced in combination with taxanes, showing maximal efficacy when administered 12 hours post-taxane treatment.